Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Anavex Life Sciences Corp. (AVXL) had Return on Tangible Equity of -35.76% for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-43.00M |
|
-- |
|
-- |
|
$52.88M |
|
$-52.88M |
|
$9.88M |
|
$-43.00M |
|
$-43.00M |
|
$-43.00M |
|
$-43.00M |
|
$-43.00M |
|
$-43.00M |
|
$-52.88M |
|
$-52.88M |
|
83.47M |
|
83.47M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$135.57M |
|
-- |
|
-- |
|
$135.57M |
|
$15.30M |
|
-- |
|
-- |
|
$15.30M |
|
$120.26M |
|
$120.26M |
|
$120.26M |
|
84.80M |
|
| Cash Flow Statement Financials | |
$-30.81M |
|
-- |
|
$11.97M |
|
$151.02M |
|
$132.19M |
|
$-18.84M |
|
$9.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.76% |
|
|
Return on Tangible Equity |
-35.76% |
-31.72% |
|
-35.76% |
|
$1.42 |
|
$-0.37 |
|
$-0.37 |
|